Barclays
LFCR icon

Barclays’s Lifecore Biomedical LFCR Stock Holding History

Barclays’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33K Sell
8,864
-37,832
-81% -$261K ﹤0.01% 4448
2025
Q4 		$382K Buy
46,696
+6,124
+15% +$45.3K ﹤0.01% 4003
2025
Q3 		$299K Sell
40,572
-7,203
-15% -$54.5K ﹤0.01% 4103
2025
Q2 		$388K Buy
47,775
+22,321
+88% +$150K ﹤0.01% 3902
2025
Q1 		$179K Sell
25,454
-8,518
-25% -$52.9K ﹤0.01% 4111
2024
Q4 		$252K Buy
33,972
+4,028
+13% +$25.7K ﹤0.01% 4200
2024
Q3 		$148K Buy
29,944
+22,489
+302% +$117K ﹤0.01% 4452
2024
Q2 		$38.2K Buy
+7,455
New +$44.1K ﹤0.01% 4304
2024
Q1 		– Sell
-19,508
Closed -$121K – 5245
2023
Q4 		$121K Sell
19,508
-11,403
-37% -$79.2K ﹤0.01% 4592
2023
Q3 		$233K Buy
30,911
+21,946
+245% +$201K ﹤0.01% 3220
2023
Q2 		$86.7K Buy
8,965
+8,917
+18,577% +$54.5K ﹤0.01% 3607
2023
Q1 		$181 Sell
48
-8,136
-99% -$45.4K ﹤0.01% 4984
2022
Q4 		$53K Buy
8,184
+6,992
+587% +$57.6K ﹤0.01% 4529
2022
Q3 		$11K Sell
1,192
-121
-9% -$1.23K ﹤0.01% 4263
2022
Q2 		$13K Sell
1,313
-2,933
-69% -$29K ﹤0.01% 4540
2022
Q1 		$49K Sell
4,246
-28,485
-87% -$317K ﹤0.01% 4128
2021
Q4 		$363K Buy
32,731
+21,055
+180% +$204K ﹤0.01% 3336
2021
Q3 		$108K Sell
11,676
-4,312
-27% -$46.9K ﹤0.01% 3877
2021
Q2 		$180K Sell
15,988
-18,299
-53% -$211K ﹤0.01% 3601
2021
Q1 		$363K Buy
34,287
+19,614
+134% +$220K ﹤0.01% 3381
2020
Q4 		$159K Buy
14,673
+2,884
+24% +$29.8K ﹤0.01% 3897
2020
Q3 		$115K Sell
11,789
-2,425
-17% -$23.1K ﹤0.01% 4168
2020
Q2 		$113K Sell
14,214
-1,391
-9% -$14.4K ﹤0.01% 4433
2020
Q1 		$135K Sell
15,605
-10,782
-41% -$112K ﹤0.01% 4575
2019
Q4 		$299K Buy
26,387
+13,873
+111% +$148K ﹤0.01% 4731
2019
Q3 		$137K Sell
12,514
-3,748
-23% -$40.8K ﹤0.01% 5236
2019
Q2 		$153K Buy
16,262
+8,779
+117% +$88.6K ﹤0.01% 5340
2019
Q1 		$92K Buy
7,483
+6,524
+680% +$79.6K ﹤0.01% 5423
2018
Q4 		$11K Sell
959
-10,687
-92% -$147K ﹤0.01% 6138
2018
Q3 		$168K Buy
11,646
+9,220
+380% +$127K ﹤0.01% 5151
2018
Q2 		$37K Sell
2,426
-3,407
-58% -$47.3K ﹤0.01% 5828
2018
Q1 		$76K Buy
5,833
+1,400
+32% +$18.4K ﹤0.01% 5587
2017
Q4 		$56K Buy
4,433
+3,011
+212% +$38.1K ﹤0.01% 5684
2017
Q3 		$18K Buy
1,422
+1,196
+529% +$15.8K ﹤0.01% 5844
2017
Q2 		$3K Sell
226
-315
-58% -$4.38K ﹤0.01% 6349
2017
Q1 		$7K Sell
541
-306
-36% -$3.87K ﹤0.01% 6185
2016
Q4 		$12K Sell
847
-852
-50% -$11.8K ﹤0.01% 5830
2016
Q3 		$22K Buy
1,699
+1,653
+3,593% +$20K ﹤0.01% 5429
2016
Q2 		$0 Hold
46
– – ﹤0.01% 6489
2016
Q1 		$0 Buy
+46
New +$505 ﹤0.01% 6311
2015
Q4 		– Sell
-256
Closed -$3K – 6303
2015
Q3 		$3K Sell
256
-1,459
-85% -$19.3K ﹤0.01% 6217
2015
Q2 		$24K Buy
1,715
+416
+32% +$6K ﹤0.01% 5570
2015
Q1 		$17K Sell
1,299
-225
-15% -$3.11K ﹤0.01% 5919
2014
Q4 		$20K Buy
1,524
+588
+63% +$7.6K ﹤0.01% 6326
2014
Q3 		$11K Buy
936
+411
+78% +$5.13K ﹤0.01% 6825
2014
Q2 		$7K Sell
525
-533
-50% -$6.27K ﹤0.01% 6992
2014
Q1 		$11K Sell
1,058
-2,296
-68% -$25.2K ﹤0.01% 6885
2013
Q4 		$40K Buy
3,354
+357
+12% +$4.26K ﹤0.01% 6330
2013
Q3 		$36K Buy
2,997
+1,078
+56% +$15K ﹤0.01% 6239
2013
Q2 		$26K Buy
+1,919
New +$26.5K ﹤0.01% 6703

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return